Exposure–Response and Tumor Growth Inhibition Analyses of the Monovalent Anti-c-MET Antibody Onartuzumab (MetMAb) in the Second- and Third-Line Non-Small Cell Lung Cancer
Crossref DOI link: https://doi.org/10.1208/s12248-016-0029-5
Published Online: 2016-12-27
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Han, Kelong
Chanu, Pascal
Jonsson, Fredrik
Winter, Helen
Bruno, René
Jin, Jin
Stroh, Mark
License valid from 2016-12-27